IP Library › Granted Patent US 10,322,080
Granted Patent B2
US 10,322,080 · App. 15/174,067 · Granted Jun 18, 2019

Cosmetic compositions

Inventors: Tiffany Florence (Addison, TX); Michelle Hines (Addison, TX); David Gan (Addison, TX)
Assignee: Mary Kay Inc.
A61K8/97A61K8/064A61K8/11A61K8/20A61K8/34A61K8/342A61K8/345A61K8/347A61K8/37A61K8/375A61K8/41A61K8/42A61K8/43A61K8/60A61K8/64A61K8/70A61K8/73A61K8/733A61Q17/04A61Q19/007A61Q19/008A61Q19/02A61Q19/08A61Q19/10A61K2800/522A61K2800/596A61K2800/70A61K2800/78A61K2800/782
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,322,080
App. No.
15/174,067
Granted
Jun 18, 2019
Kind
B2
Abstract

A method for reducing hyaluronidase activity and promoting hyaluronic acid production in skin comprising topically applying to skin in need thereof a composition comprising an effective amount of Centella asiatica stem cells to reduce hyaluronidase activity in skin, an effective amount of tetradecyl aminobutyroylvalylamino butyric urea trifluoroacetate to promote hyaluronic acid production in skin, and an effective amount of tripeptide-1 to promote hyaluronic acid production in skin.

Claims (34)

1. A method for reducing hyaluronidase activity and promoting hyaluronic acid production in skin comprising topically applying to skin in need thereof a composition comprising:

(a) 0.0001 to 0.25% by weight of Centella asiatica meristem cell culture to reduce hyaluronidase activity in skin;

(b) 0.000001 to 0.5% by weight of tetradecyl aminobutyroylvalylamino butyric urea trifluoroacetate to promote hyaluronic acid production in skin;

(c) 0.000001 to 0.5% by weight of tripeptide-1 to promote hyaluronic acid production in skin;

(d) 1 to 25% by weight glycerin; and

(e) 25 to 50% by weight water.

2. The method of claim 1 , wherein the composition is applied to a deep line or wrinkle, and wherein the composition reduce the appearance of said deep line or wrinkle.

3. The method of claim 2 , wherein the tripeptide-1 promotes collagen I, collagen III, laminin, and fibronectin production in the skin.

4. The method of claim 3 , wherein the composition is applied to facial skin or neck skin.

5. The method of claim 4 , wherein the composition is a cream or lotion or a water-in-oil emulsion.

6. The method of claim 5 , wherein after topical application the composition remains on the skin for at least 30 minutes.

7. The method of claim 6 , wherein the composition further comprises:

(f) encapsulated retinol;

(g) Punica granatum extract or sterols thereof;

(h) Codium tomentosum extract;

(i) Cinnamomum Cassia bark extract; and

(j) Glycyrrhiza glabra root extract.

8. The method of claim 1 , wherein the composition further comprises:

xanthan gum;

magnesium chloride;

urea;

glucose; and

guanidine HCL.

9. The method of claim 1 , wherein the composition is a cleanser.

10. The method of claim 1 , wherein the composition further comprises:

0.001 to 1% by weight of green tea extract.

11. The method of claim 10 , wherein the composition further comprises:

0.0005 to 1% by weight of an extract of cucumber.

12. The method of claim 11 , wherein the composition further comprises:

0.001 to 0.1% by weight of Helianthus annuus seed oil; and

0.0005 to 0.1% by weight of an extract of rose oil.

13. The method of claim 12 , wherein the composition further comprises:

0.0001 to 0.1% by weight of subtilisin; and

0.00001 to 0.1% by weight of lipase.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 6, 2016
From: FLORENCE, TIFFANY; HINES, MICHELLE; GAN, DAVID
To: MARY KAY INC.
Reel/Frame 038816/0328 →
Continuity (6)
Continuation 14963886 · Dec 9, 2015
Continuation 13468874 · May 10, 2012
Provisional Application 61550813 · Oct 24, 2011
Provisional Application 61495208 · Jun 9, 2011
Provisional Application 61484542 · May 10, 2011
Related Publication 20160279051A1 · Sep 29, 2016